Signal price

Oppenheimer cuts Integral Ad Science (NASDAQ:IAS) target price to $19.00


Integral Advertising Science (NASDAQ: IAS – Get an Assessment) had its price target reduced by Oppenheimer stock research analysts from $24.00 to $19.00 in a research note released Thursday, The Fly reports. Oppenheimer’s price target suggests a potential upside of 82.17% from the stock’s previous close.

Other analysts have also recently published research reports on the company. Barclays cut its price target on Integral Ad Science from $17.00 to $12.00 in a research report on Thursday. Raymond James upgraded Integral Ad Science from an “outperform” rating to a “strong buy” rating and raised its price target for the stock from $26.00 to $27.00 in a rating of research from Monday, March 21. Morgan Stanley raised its price target on Integral Ad Science from $25.00 to $27.00 in a Wednesday, January 19 research note. Zacks Investment Research upgraded Integral Ad Science from a “sell” rating to a “hold” rating in a research note on Tuesday. Finally, Stifel Nicolaus raised his price target on Integral Ad Science from $25.00 to $26.00 and gave the stock a “buy” rating in a Friday, March 4 research note. Two analysts gave the stock a hold rating, seven gave the stock a buy rating and one gave the stock a high buy rating. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $24.20.

NASDAQ:IAS shares opened at $10.43 on Thursday. Integral Ad Science has a fifty-two week minimum of $10.31 and a fifty-two week maximum of $29.68. The company has a 50-day moving average of $13.76 and a two-hundred-day moving average of $18.26. The company has a quick ratio of 3.01, a current ratio of 3.01 and a leverage ratio of 0.32.

Integral Ad Science (NASDAQ:IAS – Get Rating) last announced its quarterly results on Thursday, March 3. The company reported earnings per share of $0.01 for the quarter, beating analyst consensus estimates of ($0.01) by $0.02. The company posted revenue of $102.47 million in the quarter, versus analyst estimates of $95.71 million. On average, stock analysts predict that Integral Ad Science will post an EPS of 0.06 for the current fiscal year.

A number of institutional investors and hedge funds have recently changed their IAS portfolio. Royal Bank of Canada bought a new stake in shares of Integral Ad Science in Q3 worth approximately $31,000. Citigroup Inc. acquired a new position in Integral Ad Science during Q3 worth $40,000. Strs Ohio increased its position in Integral Ad Science shares by 33.3% during the first quarter. Strs Ohio now owns 5,200 shares of the company valued at $71,000 after acquiring 1,300 additional shares in the last quarter. Metropolitan Life Insurance Co NY purchased a new stake in shares of Integral Ad Science during Q3 at a value of $108,000. Finally, the New York State Common Retirement Fund purchased a new equity stake in Integral Ad Science in Q3, valued at $124,000.

About Integral Advertising Science (Get an evaluation)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, United Kingdom, Germany, Italy, Spain, Sweden, Singapore, Australia, France, Japan, Canada, India and in Brazil. The Company provides IAS Signal, a cloud-based technology platform that delivers actionable insights; and provide independent measurement and verification of digital advertising across all devices, channels and formats, including desktop, mobile, connected TV, social media, display and video.

Read more

The Fly logo

Analyst Recommendations for Integral Ad Science (NASDAQ: IAS)



Get news and reviews for Integral Ad Science Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Integral Ad Science and related companies with MarketBeat.com’s FREE daily newsletter.